Michelle Panlilio
Gerontology · Los Angeles, CANPI 1588907893
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,425 of the $8,070 with a category attached, or 79.6%. Eisai Inc. accounts for 67.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $5,467 and has fallen 98.6% since, to $78 in 2025. Among gerontology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $310.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$5K
- Genentech, Inc.$2K
- Cvrx, Inc.$78
- Smith+Nephew$70
- Neurocrine Biosciences, Inc.$66
- Sanofi-aventis U.S. LLC$50
What the payments were for
- Consulting fees$6,42580%
- Travel & lodging$95712%
- Food & beverage$6889%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 19 | $5,467 |
| Genentech, Inc. | 3 | $2,338 |
| Cvrx, Inc. | 1 | $78 |
| Smith+Nephew | 1 | $70 |
| Neurocrine Biosciences, Inc. | 1 | $66 |
| Sanofi-aventis U.S. LLC | 1 | $50 |
How this compares
$8,070 in reported general payments places this provider in the 95th percentile of 348 gerontology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 18 | $703 |
| Risperidone | 29 | $672 |
| Quetiapine Fumarate | 31 | $388 |
| Mirtazapine | 12 | $254 |
| Gabapentin | 16 | $229 |
| Trazodone Hcl | 20 | $182 |
| Citalopram HbrCitalopram Hydrobromide | 18 | $102 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Los Angeles
- Leslie TarlowLos Angeles$58K
- Elsa Pineda-FloresLos Angeles$24K
- Erica JenkinsLos Angeles$7K
- Lilit SahakyanLos Angeles$6K
- Laura LockeLos Angeles$3K
- Hawa MaparaLos Angeles$2K
- Alyssa MaskellLos Angeles$2K
- Lovely IsraelSanta Monica$95K
- Christine PartamianPorter Ranch$41K
- Maria MottaDuarte$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.